CapitalStars Financial Research Pvt Ltd

CapitalStars

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Showing posts with label Stock Market News. Show all posts
Showing posts with label Stock Market News. Show all posts

Friday, 25 May 2018

Capitalstars news update-IDBI Q4 loss widens on provisioning as NPAs surge to 28%

capitalstars


State-run IDBI Bank on Friday posted a loss of Rs 5,662.76 crore for the fourth quarter ending March, its numbers being pulled down further by its deteriorating bad loans.
IDBI had reported a net loss of Rs 3,199.77 crore in the corresponding quarter of the last fiscal, the bank said in a stock exchange filing. It has now reported losses for the sixth successive quarter.
Its net interest income fell 44 per cent to Rs 915.47 crore during the quarter in consideration, as compared to Rs 1,633.29 crore in the same quarter last year.
The asset quality of the lender dropped further with the percentage of gross non-performing assets (NPAs), or bad loans, shooting up 27.95 per cent in the quarter under review, as against 21.25 per cent in the fourth quarter of 2017-18 and 24.72 per cent in the last quarter.
IDBI's gross NPAs during the fourth quarter went up to Rs 55,588.26 crore against Rs 44,752.59 crore in the same quarter last year.
Provisions and contingencies rose to Rs 10,544.34 crore during the quarter in question, over Rs 5,864.65 crore in the corresponding quarter last year and Rs 4,655.80 crore in the previous quarter ending December.
The divergence as defined by the Reserve Bank of India in IDBI's gross and net NPAs for 2016-17 stood at Rs 10,282 crore and Rs 5,818 crore, respectively.
The IDBI bank stock closed on Friday at Rs 65.10 a share, down Rs 2.10, or by 3.13 per cent on its previous close on the BSE.
Get more details here:-




* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Wednesday, 28 February 2018

Capitalstars Updates: Dilip Buildcon declared as the lowest bidder for a road construction project worth Rs2,013cr: 28 Feb 2018


Capitalstars Updates: Dilip Buildcon

The project will be executed on Hybrid Annuity Mode in the state of Andhra Pradesh

Dilip Buildcon Ltd has been declared as the lowest bidder (L1) by the NHAI for a Hybrid Annuity Project in the state of Andhra Pradesh. The scope of the project involves six laning of Anandapuram-Pendurthi-Anakapalli section of NH-5 (new NH-16). The project is part of the Bharatmala Pariyojana programme. The construction period is 30 months and the operation period is 15 years from commercial operation date. The length of the project is 50.8kms.

Dilip Buildcon Ltd’s order book stood at Rs12,357cr as of Q3FY18, which was 2.4x its trailing twelve months revenues. DBL has guided for order inflows of Rs8,000-10,000cr in FY18E, on the back of strong ordering of around Rs1.4lakh cr from NHAI. The company has already received orders worth Rs3,500cr as of Q3FY18 end. We expect the company’s order book to report annual compounded growth of 15% over FY18-20E.

Dilip Buildcon Ltd is currently trading at Rs945.20 up by Rs5 or 0.53% from its previous closing of Rs940.20 on the BSE.


Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us. 


Get more details here:-
Stock Tips
Share Market Company

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Monday, 26 February 2018

Capitalstars Updates: Dr Reddy's receives unfavourable EIR for its Srikakulam plant: 26 Feb 2018

Capitalstars Updates: Dr Reddy's


The company has launched gRenvela from this site while gCopaxone has also been filed from this site.

Dr Reddy’s has announced that the company has received an unfavorable Established Inspection Report (EIR) for its API facility in Srikakulam. The EIR mentions of OAI (official action indicated) meaning that company will have to provide more details to the USFDA. This means that the plant will continue to remain under the warning letter and one has to see the next course of the action by USFDA.

The OAI is issued when there are objectionable conditions found at the manufacturing facility.

The company has indicated that the company continues to market drugs in the US markets despite the warning letter, however, it has implications for the future drug approvals. Srikakulam plant has two dosages i.e. oral solid and topicals. The company has launched gRenvela from this site while gCopaxone has also been filed from this site.

The company in November 2015 received a warning letter for its two API facilities located at Miryalaguda and Srikakulam and a formulation facility at Duvvada. Of this, Miryalaguda API plant has been cleared after successful re-inspection, while Duvvada formulations and Srikakulam API facility remain under the warning letter.

In April 2017 re-inspection, API facility in Srikakulam received two observations by the US drug regulator. These observations were in the areas of high-performance liquid chromatography (‘HPLC’) maintenance and the management of soft copies of chromatograms. In the warning letter, USFDA had also found previously undisclosed quality-control lab at the facility.

This is a negative news on the counter.


Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us. 


Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Saturday, 17 February 2018

Capitalstars Updates: PSU Banks – heading towards a collapse?: 17 Feb 2018

Capitalstars Updates: PSU Banks


The Indian PSU Bank Index witnessed positive momentum from January 1, 2018 to January 24, 2018. Nifty PSU Bank Index gained 7.8% in the aforementioned period. However, with the announcement of recapitalization reforms followed by NPA reforms, the dark days of PSU banks began. Moreover, the nail in the coffin was the emergence of PNB’s ~Rs11,600cr fraud. The sector witnessed a significant slump of 15.1% (between January 25-February 16, 2018).

Story in numbers 


Exhibit 1: Performance of PSU Stocks over January 1 – 24, 2018

StockPrice as on Jan 1 2018Price as on Jan 24 2018Gain/(Loss) %
Punjab National Bank169.8194.714.7
Bank Of Baroda161.5178.410.4
IDBI Bank Ltd.60.465.48.3
State Bank Of India307.1329.97.4
Indian Bank377.2403.16.9
Oriental Bank Of Commerce121.9129.56.2
Canara Bank360.7379.35.1
Syndicate Bank79.882.33.2
Union Bank Of India144.9148.92.8
Bank Of India169.9172.51.5
Andhra Bank58.458.80.7
Allahabad Bank73.873.1(0.9)

The government announced on January 24, 2018 about the recapitalization plans i.e. of infusing Rs88,139cr capital in 20 public sector banks before March 31, 2018. Under the recapitalization plan Rs52,300cr will be given to the weaker banks and the remaining amount will be received by healthier banks. This move was, however, in contrast to market expectations, as per the media reports. Hence, the PSU Bank Index witnessed a fall the very next day of this announcement. The icing on the cake was the RBI’s announcement of new rules for recognition of stressed assets by commercial banks.

RBI has also withdrawn the existing mechanism which included Strategic Debt Restructuring Scheme (SDR) and Scheme for Sustainable Structuring of Stressed Assets (S4A) and Corporate Debt Restructuring Scheme, The Joint Lenders’ Forum (JLF), as an institutional mechanism for resolution of stressed accounts also stands discontinued. 

PNB’s declaration of ~Rs11,600cr fraud against jeweller Nirav Modi dragged the performance of Nifty PSU Bank index.  Nifty PSU Bank Index was down 15.1% over January 25, 2018 - February 16, 2018. 

Exhibit 2: Performance of PSU Stocks over January 25, 2018- February 16, 2018.

Company NamePrice as on Jan 25, 2018Price as on Feb 16, 2018(Loss) %
Punjab National Bank180.9125.6(30.6)
Bank Of India169.4130.5(23.0)
Syndicate Bank76.759.6(22.3)
Allahabad Bank70.154.9(21.8)
Andhra Bank55.946.6(16.6)
Union Bank Of India141.8118.4(16.5)
Canara Bank361.4307.5(14.9)
Oriental Bank Of Commerce123.2105.6(14.3)
State Bank Of India313.2271.7(13.3)
Indian Bank377.8337.0(10.8)
Bank Of Baroda167.2152.4(8.8)
IDBI Bank Ltd.65.161.8(5.1)

Exhibit 3: Performance of PSU Stocks over January 01, 2018- February 16, 2018.

StockPrice as on Jan 1 2018Price as on Feb 16, 2018Gain/ (Loss) %
Punjab National Bank169.8125.6(26.0)
Allahabad Bank73.854.9(25.6)
Syndicate Bank79.859.6(25.3)
Bank Of India169.9130.5(23.2)
Andhra Bank58.446.6(20.2)
Union Bank Of India144.9118.4(18.3)
Canara Bank360.7307.5(14.7)
Oriental Bank Of Commerce121.9105.6(13.4)
State Bank Of India307.1271.7(11.5)
Indian Bank377.2337(10.6)
Bank Of Baroda161.5152.4(5.6)
IDBI Bank Ltd.60.461.82.4

New norms on bad loans are likely to result in an increase in credit provisioning. In addition, it is expected to have a detrimental impact on balance sheet of the PSU banks in the coming quarters. Further, PNB’s fraud has entangled various other PSU banks leading to a significant down trend in the stocks under PSU Bank Index. The magnanimity of the PNB scam has put creditability of the PSU banks at stake. 

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us. 


Get more details here:-


* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647